AstraZeneca plc (LON:AZN) had its target price trimmed by Liberum Capital from GBX 5,200 ($64.98) to GBX 5,100 ($63.73) in a research report released on Monday. The firm currently has a buy rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued reports about the stock. Citigroup Inc. reiterated a buy rating […]
